Long-term follow-up study of patients who have previously been exposed to UCART19

JRCT ID: jRCT2013190001

Registered date:28/04/2019

Basic Information

• Recruitment status: Not Recruiting
• Health condition(s) or Problem(s) studied: advanced lymphoid malignancies
• Date of first enrollment: 12/03/2020
• Target sample size: 200
• Countries of recruitment: UK,Japan,USA,Japan,France,Japan,Belgium,Japan
• Study type: Interventional
• Intervention(s): UCART19 administration in parent studies

Outcome(s)

• Primary Outcome: To evaluate the long-term safety of patients with advanced lymphoid malignancies who have been previously administered with UCART19
• Secondary Outcome: To assess the long term anti leukemic activity of UCART19 etc

Key inclusion & exclusion criteria

• Age minimum: Not applicable
• Age maximum: Not applicable
• Gender: Both
• Include criteria: All patients dosed with UCART19 must be enrolled in the long-term follow up study after the completion of the parent study.
• Exclude criteria: No exclusion criteria for this study.

Related Information

• Primary Sponsor: clinical operation department International center for therapeutic research
• Secondary ID(s): NCT02735083